Gene Wars: The Politics of Biotechnology
Rapid and radical developments are occurring in laboratories that will shape the future. Genetic engineering and biotechnology hold promise and peril. New varieties of plants and plant-derived medicines are being literally invented by multinational corporations. Anything that can be genetically engineered can be patented and monopolized. The biotech industry says the new strains of products like corn and soy beans are safe. Critics are not so sure. They say corporate control of the gene pool may threaten global food supplies.
Recorded at the University of Colorado at Boulder.
Kristin Dawkins is a leading expert on the politics of biotechnology and director of research and policy analyst at the Institute for Agriculture and Trade Policy in Minneapolis, where she directs work on ecological economics and the links between trade and environmental policy. She previously directed the Jobs in Energy Project in Philadelphia. She is the author of Gene Wars: The Politics of Biotechnology.